Publications

  1. Allen SV, Pruthi S, Suman VJ, Hoskin TL, Vachon CM, Ingle JN, Olson JE. Evaluation of the Aromatase Inhibition Potential of Freeze-Dried Grape Powder. J Diet Suppl. 2014 Aug 28. [Epub ahead of print]
    View PubMed
  2. Bible KC, Suman VJ, Molina JR, Smallridge RC, Maples WJ, Menefee ME, Rubin J, Karlin N, Sideras K, Morris JC 3rd, McIver B, Hay I, Fatourechi V, Burton JK, Webster KP, Bieber C, Traynor AM, Flynn PJ, Cher Goh B, Isham CR, Harris P, Erlichman C, Endocrine A multicenter phase 2 trial of pazopanib in metastatic and progressive medullary thyroid carcinoma: MC057H. J Clin Endocrinol Metab. 2014 May; 99(5):1687-93. Epub 2014 Feb 25.
    View PubMed
  3. Hawse JR, Pitel KS, Cicek M, Philbrick KA, Gingery A, Peters KD, Syed FA, Ingle JN, Suman VJ, Iwaniec UT, Turner RT, Spelsberg TC, Subramaniam M. TGFbeta inducible early gene-1 plays an important role in mediating estrogen signaling in the skeleton. J Bone Miner Res. 2014 May; 29(5):1206-16.
    View PubMed
  4. Province MA, Goetz MP, Brauch H, Flockhart DA, Hebert JM, Whaley R, Suman VJ, Schroth W, Winter S, Zembutsu H, Mushiroda T, Newman WG, Lee MT, Ambrosone CB, Beckmann MW, Choi JY, Dieudonne AS, Fasching PA, Ferraldeschi R, Gong L, Haschke-Becher E, Howell CYP2D6 genotype and adjuvant tamoxifen: meta-analysis of heterogeneous study populations. Clin Pharmacol Ther. 2014 Feb; 95(2):216-27. Epub 2013 Sep 23.
    View PubMed
  5. D'Assoro AB, Liu T, Quatraro C, Amato A, Opyrchal M, Leontovich A, Ikeda Y, Ohmine S, Lingle W, Suman V, Ecsedy J, Iankov I, Di Leonardo A, Ayers-Inglers J, Degnim A, Billadeau D, McCubrey J, Ingle J, Salisbury JL, Galanis E. The mitotic kinase Aurora--a promotes distant metastases by inducing epithelial-to-mesenchymal transition in ERalpha(+) breast cancer cells. Oncogene. 2014 Jan 30; 33(5):599-610. Epub 2013 Jan 21.
    View PubMed
  6. Buzdar AU, Suman VJ, Meric-Bernstam F, Leitch AM, Ellis MJ, Boughey JC, Unzeitig G, Royce M, McCall LM, Ewer MS, Hunt KK, American College of Surgeons Oncology Group investigators. Fluorouracil, epirubicin, and cyclophosphamide (FEC-75) followed by paclitaxel plus trastuzumab versus paclitaxel plus trastuzumab followed by FEC-75 plus trastuzumab as neoadjuvant treatment for patients with HER2-positive breast cancer (Z1041): a random ised, controlled, phase 3 trial. Lancet Oncol. 2013 Dec; 14(13):1317-25. Epub 2013 Nov 13
    View PubMed
  7. Boughey JC, Suman VJ, Mittendorf EA, Ahrendt GM, Wilke LG, Taback B, Leitch AM, Kuerer HM, Bowling M, Flippo-Morton TS, Byrd DR, Ollila DW, Julian TB, McLaughlin SA, McCall L, Symmans WF, Le-Petross HT, Haffty BG, Buchholz TA, Nelson H, Hunt KK, Alliance Sentinel lymph node surgery after neoadjuvant chemotherapy in patients with node-positive breast cancer: the ACOSOG Z1071 (Alliance) clinical trial. JAMA. 2013 Oct 9; 310(14):1455-61.
    View PubMed
  8. Ma CX, Suman VJ, Goetz M, Haluska P, Moynihan T, Nanda R, Olopade O, Pluard T, Guo Z, Chen HX, Erlichman C, Ellis MJ, Fleming GF. A phase I trial of the IGF-1R antibody Cixutumumab in combination with temsirolimus in patients with metastatic breast cancer. Breast Cancer Res Treat. 2013 May; 139(1):145-53. Epub 2013 Apr 19.
    View PubMed
  9. Vachon CM, Suman VJ, Brandt KR, Kosel ML, Buzdar AU, Olson JE, Wu FF, Flickinger LM, Ursin G, Elliott CR, Shepherd L, Weinshilboum RM, Goss PE, Ingle JN. Mammographic breast density response to aromatase inhibition. Clin Cancer Res. 2013 Apr 15; 19(8):2144-53. Epub 2013 Mar 06.
    View PubMed
  10. Cheville AL, Brinkmann DH, Ward SB, Durski J, Laack NN, Yan E, Schomberg PJ, Garces YI, Suman VJ, Petersen IA. The addition of SPECT/CT lymphoscintigraphy to breast cancer radiation planning spares lymph nodes critical for arm drainage. Int J Radiat Oncol Biol Phys. 2013 Mar 15; 85(4):971-7.
    View PubMed
  11. Kottschade LA, Suman VJ, Perez DG, McWilliams RR, Kaur JS, Amatruda TT 3rd, Geoffroy FJ, Gross HM, Cohen PA, Jaslowski AJ, Kosel ML, Markovic SN. A randomized phase 2 study of temozolomide and bevacizumab or nab-paclitaxel, carboplatin, and bevacizumab in patients with unresectable stage IV melanoma : a North Central Cancer Treatment Group study, N0775. Cancer. 2013 Feb 1; 119(3):586-92. Epub 2012 Aug 22.
    View PubMed
  12. Goetz MP, Suman VJ, Hoskin TL, Gnant M, Filipits M, Safgren SL, Kuffel M, Jakesz R, Rudas M, Greil R, Dietze O, Lang A, Offner F, Reynolds CA, Weinshilboum RM, Ames MM, Ingle JN. CYP2D6 metabolism and patient outcome in the Austrian Breast and Colorectal Cancer Study Group trial (ABCSG) 8. Clin Cancer Res. 2013 Jan 15; 19(2):500-7. Epub 2012 Dec 04.
    View PubMed
  13. Isham CR, Bossou AR, Negron V, Fisher KE, Kumar R, Marlow L, Lingle WL, Smallridge RC, Sherman EJ, Suman VJ, Copland JA, Bible KC. Pazopanib enhances paclitaxel-induced mitotic catastrophe in anaplastic thyroid cancer. Sci Transl Med. 2013 Jan 2; 5(166):166ra3.
    View PubMed
  14. Jatoi A, Allred JB, Suman VJ, Creagan ET, Croghan GA, Amatruda T, Markovic SN. Is Age >/= 70 Years an Important Predictor of Adverse Events Among Patients Enrolled in Metastatic Melanoma Trials? Findings from Pooled Analyses of Therapeutic Trials. J Geriatr Oncol. 2012 Oct 1; 3(4):307-11. Epub 2012 May 7
    View PubMed
  15. Pruthi S, Yang L, Sandhu NP, Ingle JN, Beseler CL, Suman VJ, Cavalieri EL, Rogan EG. Evaluation of serum estrogen-DNA adducts as potential biomarkers for breast cancer risk. J Steroid Biochem Mol Biol. 2012 Oct; 132(1-2):73-9. Epub 2012 Feb 24.
    View PubMed
  16. Galanis E, Markovic SN, Suman VJ, Nuovo GJ, Vile RG, Kottke TJ, Nevala WK, Thompson MA, Lewis JE, Rumilla KM, Roulstone V, Harrington K, Linette GP, Maples WJ, Coffey M, Zwiebel J, Kendra K. Phase II trial of intravenous administration of Reolysin((R)) (Reovirus Serotype-3-dearing Strain) in patients with metastatic melanoma. Mol Ther. 2012 Oct; 20(10):1998-2003. Epub 2012 Aug 07.
    View PubMed
  17. Bible KC, Suman VJ, Menefee ME, Smallridge RC, Molina JR, Maples WJ, Karlin NJ, Traynor AM, Kumar P, Goh BC, Lim WT, Bossou AR, Isham CR, Webster KP, Kukla AK, Bieber C, Burton JK, Harris P, Erlichman C, Mayo Phase 2 Consortium, Mayo Clinic Endocrine A multiinstitutional phase 2 trial of pazopanib monotherapy in advanced anaplastic thyroid cancer. J Clin Endocrinol Metab. 2012 Sep; 97(9):3179-84. Epub 2012 Jul 06.
    View PubMed
  18. Ellis MJ, Ding L, Shen D, Luo J, Suman VJ, Wallis JW, Van Tine BA, Hoog J, Goiffon RJ, Goldstein TC, Ng S, Lin L, Crowder R, Snider J, Ballman K, Weber J, Chen K, Koboldt DC, Kandoth C, Schierding WS, McMichael JF, Miller CA, Lu C, Harris CC, McLellan Whole-genome analysis informs breast cancer response to aromatase inhibition. Nature. 2012 Jun 21; 486(7403):353-60. Epub 2012 Jun 10.
    View PubMed
  19. Savova GK, Olson JE, Murphy SP, Cafourek VL, Couch FJ, Goetz MP, Ingle JN, Suman VJ, Chute CG, Weinshilboum RM. Automated discovery of drug treatment patterns for endocrine therapy of breast cancer within an electronic medical record. J Am Med Inform Assoc. 2012 Jun; 19(e1):e83-9. Epub 2011 Dec 01.
    View PubMed
  20. Harrington SC, Weroha SJ, Reynolds C, Suman VJ, Lingle WL, Haluska P. Quantifying insulin receptor isoform expression in FFPE breast tumors. Growth Horm IGF Res. 2012 Jun-Aug; 22(3-4):108-15. Epub 2012 Apr 30.
    View PubMed
  21. Bible KC, Smallridge RC, Morris JC, Molina JR, Suman VJ, Copland JA, Rubin J, Menefee ME, Sideras K, Maples WJ, McIver B, Fatourechi V, Hay I, Foote RL, Garces YI, Kasperbauer JL, Thompson GB, Grant CS, Richards ML, Sebo T, Lloyd R, Eberhardt NL, Reddi Development of a multidisciplinary, multicampus subspecialty practice in endocrine cancers. Am J Manag Care. 2012 May; 18(5):e162-7. Epub 2012 May 01.
    View PubMed
  22. Bible KC, Smallridge RC, Morris JC, Molina JR, Suman VJ, Copland JA, Rubin J, Menefee ME, Sideras K, Maples WJ, McIver B, Fatourechi V, Hay I, Foote RL, Garces YI, Kasperbauer JL, Thompson GB, Grant CS, Richards ML, Sebo T, Lloyd R, Eberhardt NL, Reddi HV Development of a multidisciplinary, multicampus subspecialty practice in endocrine cancers. J Oncol Pract. 2012 May; 8(3 Suppl):e1s-5s.
    View PubMed
  23. Goncalves R, Ma C, Luo J, Suman V, Ellis MJ. Use of neoadjuvant data to design adjuvant endocrine therapy trials for breast cancer. Nat Rev Clin Oncol. 2012 Apr; 9(4):223-9. Epub 2012 Feb 28.
    View PubMed
  24. Leontovich AA, Dronca RS, Suman VJ, Ashdown ML, Nevala WK, Thompson MA, Robinson A, Kottschade LA, Kaur JS, McWilliams RR, Ivanov LV, Croghan GA, Markovic SN. Fluctuation of systemic immunity in melanoma and implications for timing of therapy. Front Biosci (Elite Ed). 2012; 4:958-75. Epub 2012 Jan 01.
    View PubMed
  25. Perez EA, Suman VJ, Davidson NE, Gralow JR, Kaufman PA, Visscher DW, Chen B, Ingle JN, Dakhil SR, Zujewski J, Moreno-Aspitia A, Pisansky TM, Jenkins RB. Sequential versus concurrent trastuzumab in adjuvant chemotherapy for breast cancer. J Clin Oncol. 2011 Dec 1; 29(34):4491-7. Epub 2011 Oct 31.
    View PubMed
  26. Moyer AM, Suman VJ, Weinshilboum RM, Avula R, Black JL, Safgren SL, Kuffel MJ, Ames MM, Ingle JN, Goetz MP. SULT1A1, CYP2C19 and disease-free survival in early breast cancer patients receiving tamoxifen. Pharmacogenomics. 2011 Nov; 12(11):1535-43. Epub 2011 Oct 03.
    View PubMed
  27. Block MS, Suman VJ, Nevala WK, Kottschade LA, Creagan ET, Kaur JS, Quevedo JF, McWilliams RR, Markovic SN. Pilot study of granulocyte-macrophage colony-stimulating factor and interleukin-2 as immune adjuvants for a melanoma peptide vaccine. Melanoma Res. 2011 Oct; 21(5):438-45.
    View PubMed
  28. Perez EA, Romond EH, Suman VJ, Jeong JH, Davidson NE, Geyer CE Jr, Martino S, Mamounas EP, Kaufman PA, Wolmark N. Four-year follow-up of trastuzumab plus adjuvant chemotherapy for operable human epidermal growth factor receptor 2-positive breast cancer: joint analysis of data from NCCTG N9831 and NSABP B-31. J Clin Oncol. 2011 Sep 1; 29(25):3366-73. Epub 2011 Jul 18.
    View PubMed
  29. Ellis MJ, Suman VJ, Hoog J, Lin L, Snider J, Prat A, Parker JS, Luo J, DeSchryver K, Allred DC, Esserman LJ, Unzeitig GW, Margenthaler J, Babiera GV, Marcom PK, Guenther JM, Watson MA, Leitch M, Hunt K, Olson JA. Randomized phase II neoadjuvant comparison between letrozole, anastrozole, and exemestane for postmenopausal women with estrogen receptor-rich stage 2 to 3 breast cancer: clinical and biomarker outcomes and predictive value of the baseline PAM50-based intrinsic subtype--ACOSOG Z1031. J Clin Oncol. 2011 Jun 10; 29(17):2342-9. Epub 2011 May 09.
    View PubMed
  30. Kottschade LA, Suman VJ, Amatruda T 3rd, McWilliams RR, Mattar BI, Nikcevich DA, Behrens R, Fitch TR, Jaslowski AJ, Markovic SN. A phase II trial of nab-paclitaxel (ABI-007) and carboplatin in patients with unresectable stage IV melanoma : a North Central Cancer Treatment Group Study, N057E(1). Cancer. 2011 Apr 15; 117(8):1704-10. Epub 2010 Nov 08.
    View PubMed
  31. Bible KC, Suman VJ, Molina JR, Smallridge RC, Maples WJ, Menefee ME, Rubin J, Sideras K, Morris JC 3rd, McIver B, Burton JK, Webster KP, Bieber C, Traynor AM, Flynn PJ, Goh BC, Tang H, Ivy SP, Erlichman C, Endocrine Malignancies Disease Oriented Group, Ma Efficacy of pazopanib in progressive, radioiodine-refractory, metastatic differentiated thyroid cancers: results of a phase 2 consortium study. Lancet Oncol. 2010 Oct; 11(10):962-72. Epub 2010 Sep 17
    View PubMed
  32. Croghan GA, Suman VJ, Maples WJ, Albertini M, Linette G, Flaherty L, Eckardt J, Ma C, Markovic SN, Erlichman C. A study of paclitaxel, carboplatin, and bortezomib in the treatment of metastatic malignant melanoma: a phase 2 consortium study. Cancer. 2010 Jul 15; 116(14):3463-8.
    View PubMed
  33. Litzow MR, Peethambaram PP, Safgren SL, Keeney GL, Ansell SM, Dispenzieri A, Elliott MA, Gastineau DA, Gertz MA, Inwards DJ, Lacy MQ, Micallef IN, Porrata LF, Lingle WL, Hartmann LC, Frost MH, Barrette BA, Long HJ, Suman VJ, Reid JM, Ames MM, Kaufmann Phase I trial of autologous hematopoietic SCT with escalating doses of topotecan combined with CY and carboplatin in patients with relapsed or persistent ovarian or primary peritoneal carcinoma. Bone Marrow Transplant. 2010 Mar; 45(3):490-7. Epub 2009 Aug 03.
    View PubMed
  34. Wang L, Ellsworth KA, Moon I, Pelleymounter LL, Eckloff BW, Martin YN, Fridley BL, Jenkins GD, Batzler A, Suman VJ, Ravi S, Dixon JM, Miller WR, Wieben ED, Buzdar A, Weinshilboum RM, Ingle JN. Functional genetic polymorphisms in the aromatase gene CYP19 vary the response of breast cancer patients to neoadjuvant therapy with aromatase inhibitors. Cancer Res. 2010 Jan 1; 70(1):319-28.
    View PubMed
  35. Schroth W, Goetz MP, Hamann U, Fasching PA, Schmidt M, Winter S, Fritz P, Simon W, Suman VJ, Ames MM, Safgren SL, Kuffel MJ, Ulmer HU, Bolander J, Strick R, Beckmann MW, Koelbl H, Weinshilboum RM, Ingle JN, Eichelbaum M, Schwab M, Brauch H. Association between CYP2D6 polymorphisms and outcomes among women with early stage breast cancer treated with tamoxifen. JAMA. 2009 Oct 7; 302(13):1429-36.
    View PubMed
  36. Grant CS, Ingle JN, Suman VJ, Dumesic DA, Wickerham DL, Gelber RD, Flynn PJ, Weir LM, Intra M, Jones WO, Perez EA, Hartmann LC. Menstrual cycle and surgical treatment of breast cancer: findings from the NCCTG N9431 study. J Clin Oncol. 2009 Aug 1; 27(22):3620-6. Epub 2009 Jun 01.
    View PubMed
  37. Halyard MY, Pisansky TM, Dueck AC, Suman V, Pierce L, Solin L, Marks L, Davidson N, Martino S, Kaufman P, Kutteh L, Dakhil SR, Perez EA. Radiotherapy and adjuvant trastuzumab in operable breast cancer: tolerability and adverse event data from the NCCTG Phase III Trial N9831. J Clin Oncol. 2009 Jun 1; 27(16):2638-44. Epub 2009 Apr 06.
    View PubMed
  38. Perez DG, Suman VJ, Fitch TR, Amatruda T 3rd, Morton RF, Jilani SZ, Constantinou CL, Egner JR, Kottschade LA, Markovic SN. Phase 2 trial of carboplatin, weekly paclitaxel, and biweekly bevacizumab in patients with unresectable stage IV melanoma: a North Central Cancer Treatment Group study, N047A. Cancer. 2009 Jan 1; 115(1):119-27.
    View PubMed
  39. Kottschade LA, Suman VJ, Lowe V, Markovic SN. Positron emission tomography in early detection of relapse in high-risk melanoma patients: A retrospective review. Community Oncol. 2009; 6(8):344-7.
    View PubMed
  40. Markovic SN, Suman VJ, Nevala WK, Geeraerts L, Creagan ET, Erickson LA, Rowland KM Jr, Morton RF, Horvath WL, Pittelkow MR. A dose-escalation study of aerosolized sargramostim in the treatment of metastatic melanoma: an NCCTG Study. Am J Clin Oncol. 2008 Dec; 31(6):573-9.
    View PubMed
  41. Goetz MP, Suman VJ, Couch FJ, Ames MM, Rae JM, Erlander MG, Ma XJ, Sgroi DC, Reynolds CA, Lingle WL, Weinshilboum RM, Flockhart DA, Desta Z, Perez EA, Ingle JN. Cytochrome P450 2D6 and homeobox 13/interleukin-17B receptor: combining inherited and tumor gene markers for prediction of tamoxifen resistance. Clin Cancer Res. 2008 Sep 15; 14(18):5864-8.
    View PubMed
  42. Suman VJ, Dueck A, Sargent DJ. Clinical trials of novel and targeted therapies: endpoints, trial design, and analysis. Cancer Invest. 2008 Jun; 26(5):439-44.
    View PubMed
  43. Gilbert JA, Goetz MP, Reynolds CA, Ingle JN, Giordano KF, Suman VJ, Blair HE, Jenkins RB, Lingle WL, Reinholz MM, Adjei AA, Ames MM. Molecular analysis of metaplastic breast carcinoma: high EGFR copy number via aneusomy. Mol Cancer Ther. 2008 Apr; 7(4):944-51.
    View PubMed
  44. Perez EA, Suman VJ, Davidson NE, Sledge GW, Kaufman PA, Hudis CA, Martino S, Gralow JR, Dakhil SR, Ingle JN, Winer EP, Gelmon KA, Gersh BJ, Jaffe AS, Rodeheffer RJ. Cardiac safety analysis of doxorubicin and cyclophosphamide followed by paclitaxel with or without trastuzumab in the North Central Cancer Treatment Group N9831 adjuvant breast cancer trial. J Clin Oncol. 2008 Mar 10; 26(8):1231-8. Epub 2008 Feb 04.
    View PubMed
  45. Korn EL, Liu PY, Lee SJ, Chapman JA, Niedzwiecki D, Suman VJ, Moon J, Sondak VK, Atkins MB, Eisenhauer EA, Parulekar W, Markovic SN, Saxman S, Kirkwood JM. Meta-analysis of phase II cooperative group trials in metastatic stage IV melanoma to determine progression-free and overall survival benchmarks for future phase II trials. J Clin Oncol. 2008 Feb 1; 26(4):527-34.
    View PubMed
  46. Alberts SR, Suman VJ, Pitot HC, Camoriano JK, Rubin J. Use of KW-2189, a DNA Minor Groove-Binding Agent, in Patients with Hepatocellular Carcinoma: A North Central Cancer Treatment Group (NCCTG) Phase II Clinical Trial. Int J Gastrointest Cancer. 2008 Jan 03. [Epub ahead of print]
    View PubMed
  47. Markovic S, Suman V, Nevala W, Geeraerts L, Pittelkow M, Ingle J, Creagan E, Kaur J, Erickson L, Rowland K, Morton R, Horvath W. Autologous Anti-Tumor Immunization: A Dose-Escalation Study of Aerosolized Sargramostim (Granulocyte Macrophage Colony Stimulating Factor) in the Treatment of Metastatic Melanoma to the Lung. Am J Clin Oncol. 2008; 31:573-9.
    View PubMed
  48. Markovic SN, Suman VJ, Rao RA, Ingle JN, Kaur JS, Erickson LA, Pitot HC, Croghan GA, McWilliams RR, Merchan J, Kottschade LA, Nevala WK, Uhl CB, Allred J, Creagan ET. A phase II study of ABT-510 (thrombospondin-1 analog) for the treatment of metastatic melanoma. Am J Clin Oncol. 2007 Jun; 30(3):303-9.
    View PubMed
  49. Vachon CM, Ingle JN, Suman VJ, Scott CG, Gottardt H, Olson JE, Goss PE. Pilot study of the impact of letrozole vs. placebo on breast density in women completing 5 years of tamoxifen. Breast. 2007 Apr; 16(2):204-10. Epub 2006 Dec 04.
    View PubMed
  50. Goetz MP, Knox SK, Suman VJ, Rae JM, Safgren SL, Ames MM, Visscher DW, Reynolds C, Couch FJ, Lingle WL, Weinshilboum RM, Fritcher EG, Nibbe AM, Desta Z, Nguyen A, Flockhart DA, Perez EA, Ingle JN. The impact of cytochrome P450 2D6 metabolism in women receiving adjuvant tamoxifen. Breast Cancer Res Treat. 2007 Jan; 101(1):113-21. Epub 2006 Nov 18.
    View PubMed
  51. Alberts SR, Suman VJ, Pitot HC, Camoriano JK, Rubin J. Use of KW-2189, a DNA minor groove-binding agent, in patients with hepatocellular carcinoma: a north central cancer treatment group (NCCTG) phase II clinical trial. J Gastrointest Cancer. 2007; 38(1):10-4.
    View PubMed
  52. Markovic SN, Suman VJ, Ingle JN, Kaur JS, Pitot HC, Loprinzi CL, Rao RD, Creagan ET, Pittelkow MR, Allred JB, Nevala WK, Celis E. Peptide vaccination of patients with metastatic melanoma: improved clinical outcome in patients demonstrating effective immunization. Am J Clin Oncol. 2006 Aug; 29(4):352-60.
    View PubMed
  53. Perez EA, Suman VJ, Davidson NE, Martino S, Kaufman PA, Lingle WL, Flynn PJ, Ingle JN, Visscher D, Jenkins RB. HER2 testing by local, central, and reference laboratories in specimens from the North Central Cancer Treatment Group N9831 intergroup adjuvant trial. J Clin Oncol. 2006 Jul 1; 24(19):3032-8.
    View PubMed
  54. Ingle JN, Suman VJ, Mailliard JA, Kugler JW, Krook JE, Michalak JC, Pisansky TM, Wold LE, Donohue JH, Goetz MP, Perez EA. Randomized trial of tamoxifen alone or combined with fluoxymesterone as adjuvant therapy in postmenopausal women with resected estrogen receptor positive breast cancer. North Central Cancer Treatment Group Trial 89-30-52. Breast Cancer Res Treat. 2006 Jul; 98(2):217-22. Epub 2006 Mar 15.
    View PubMed
  55. Goetz MP, Suman VJ, Ingle JN, Nibbe AM, Visscher DW, Reynolds CA, Lingle WL, Erlander M, Ma XJ, Sgroi DC, Perez EA, Couch FJ. A two-gene expression ratio of homeobox 13 and interleukin-17B receptor for prediction of recurrence and survival in women receiving adjuvant tamoxifen. Clin Cancer Res. 2006 Apr 1; 12(7 Pt 1):2080-7.
    View PubMed
  56. Baweja M, Suman VJ, Fitch TR, Mailliard JA, Bernath A, Rowland KM, Alberts SR, Kaur JS, Perez EA, Ncctg. Phase II trial of oral vinorelbine for the treatment of metastatic breast cancer in patients > or = 65 years of age: an NCCTG study. Ann Oncol. 2006 Apr; 17(4):623-9. Epub 2006 Mar 06.
    View PubMed
  57. Ingle JN, Suman VJ, Rowland KM, Mirchandani D, Bernath AM, Camoriano JK, Fishkin PA, Nikcevich DA, Perez EA, North Central Cancer Treatment Group Trial N0032. Fulvestrant in women with advanced breast cancer after progression on prior aromatase inhibitor therapy: North Central Cancer Treatment Group Trial N0032. J Clin Oncol. 2006 Mar 1; 24(7):1052-6.
    View PubMed
  58. Long HJ 3rd, Nelimark RA, Podratz KC, Suman V, Keeney GL, Nikcevich DA, Kugler JW, Rowland KM Jr, Kardinal CG, Wos EJ. Phase III comparison of methotrexate, vinblastine, doxorubicin, and cisplatin (MVAC) vs. doxorubicin and cisplatin (AC) in women with advanced primary or recurrent metastatic carcinoma of the uterine endometrium. Gynecol Oncol. 2006 Mar; 100(3):501-5. Epub 2005 Sep 26.
    View PubMed
  59. Goetz MP, Rae JM, Suman VJ, Safgren SL, Ames MM, Visscher DW, Reynolds C, Couch FJ, Lingle WL, Flockhart DA, Desta Z, Perez EA, Ingle JN. Pharmacogenetics of tamoxifen biotransformation is associated with clinical outcomes of efficacy and hot flashes. J Clin Oncol. 2005 Dec 20; 23(36):9312-8.
    View PubMed
  60. Perez EA, Suman VJ, Rowland KM, Ingle JN, Salim M, Loprinzi CL, Flynn PJ, Mailliard JA, Kardinal CG, Krook JE, Thrower AR, Visscher DW, Jenkins RB. Two concurrent phase II trials of paclitaxel/carboplatin/trastuzumab (weekly or every-3-week schedule) as first-line therapy in women with HER2-overexpressing metastatic breast cancer: NCCTG study 983252. Clin Breast Cancer. 2005 Dec; 6(5):425-32.
    View PubMed
  61. Romond EH, Perez EA, Bryant J, Suman VJ, Geyer CE Jr, Davidson NE, Tan-Chiu E, Martino S, Paik S, Kaufman PA, Swain SM, Pisansky TM, Fehrenbacher L, Kutteh LA, Vogel VG, Visscher DW, Yothers G, Jenkins RB, Brown AM, Dakhil SR, Mamounas EP, Lingle WL, Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer. N Engl J Med. 2005 Oct 20; 353(16):1673-84.
    View PubMed
  62. Ghosh K, Melton LJ, Suman VJ, Grant CS, Sterioff S, Brandt KR, Branch C, Sellers TA, Hartmann LC. Breast biopsy utilization - A population-based study. Archives of Internal Medicine. 2005 Jul 25; 165(14):1593-8.
    View PubMed
  63. Hartmann LC, Sellers TA, Frost MH, Lingle WL, Degnim AC, Ghosh K, Vierkant RA, Maloney SD, Pankratz VS, Hillman DW, Suman VJ, Johnson J, Blake C, Tlsty T, Vachon CM, Melton LJ 3rd, Visscher DW. Benign breast disease and the risk of breast cancer. N Engl J Med. 2005 Jul 21; 353(3):229-37.
    View PubMed
  64. Reinholz MM, Nibbe A, Jonart LM, Kitzmann K, Suman VJ, Ingle JN, Houghton R, Zehentner B, Roche PC, Lingle WL. Evaluation of a panel of tumor markers for molecular detection of circulating cancer cells in women with suspected breast cancer. Clin Cancer Res. 2005 May 15; 11(10):3722-32.
    View PubMed
  65. Ingle JN, Suman VJ. Aromatase inhibitors for therapy of advanced breast cancer. J Steroid Biochem Mol Biol. 2005 May; 95(1-5):113-9.
    View PubMed
  66. Lafky JM, Baron AT, Cora EM, Hillman DW, Suman VJ, Perez EA, Ingle JN, Maihle NJ. Serum soluble epidermal growth factor receptor concentrations decrease in postmenopausal metastatic breast cancer patients treated with letrozole. Cancer Res. 2005 Apr 15; 65(8):3059-62.
    View PubMed
  67. Dowdy SC, Metzinger DS, Gebhart JB, Srivatsa P, Haddock MG, Suman VJ, Podratz KC. Salvage whole-abdominal radiation therapy after second-look laparotomy or secondary debulking surgery in patients with ovarian cancer. Gynecol Oncol. 2005 Feb; 96(2):389-94.
    View PubMed
  68. Perez EA, Suman VJ, Fitch TR, Mailliard JA, Ingle JN, Cole JT, Veeder MH, Flynn PJ, Walsh DJ, Addo FK. A phase II trial of docetaxel and carboplatin as first-line chemotherapy for metastatic breast cancer: NCCTG study N9932. Oncology. 2005; 69(2):117-21. Epub 2005 Aug 23.
    View PubMed
  69. Perez EA, Suman VJ, Davidson NE, Kaufman PA, Martino S, Dakhil SR, Ingle JN, Rodeheffer RJ, Gersh BJ, Jaffe AS. Effect of doxorubicin plus cyclophosphamide on left ventricular ejection fraction in patients with breast cancer in the North Central Cancer Treatment Group N9831 Intergroup Adjuvant Trial. J Clin Oncol. 2004 Sep 15; 22(18):3700-4.
    View PubMed
  70. Reinholz MM, An MW, Johnsen SA, Subramaniam M, Suman VJ, Ingle JN, Roche PC, Spelsberg TC. Differential gene expression of TGF inducible early gene (TIEG), Smad7, Smad2 and Bard1 in normal and malignant breast tissue. Breast Cancer Research & Treatment. 2004 Jul; 86(1):75-88.
    View PubMed
  71. Miller DV, Leontovich AA, Lingle WL, Suman VJ, Mertens ML, Lillie J, Ingalls KA, Perez EA, Ingle JN, Couch FJ, Visscher DW. Utilizing Nottingham Prognostic Index in microarray gene expression profiling of breast carcinomas. Mod Pathol. 2004 Jul; 17(7):756-64.
    View PubMed
  72. Perez E, Suman V, Davidson N, Kaufman P, Martino S, Dakhil S, Rodeheffer R, Gersh B, Jaffe A Effect of Dozorubicin Plus Cyclophosphamide on Left Ventricular Ejection Fraction in Patients With Breast Cancer in the NCCTG N9831 Intergroup Adjuvant Trial J Clin Pathol. 2004; 22:3700-3704.
    View PubMed
  73. Dowdy SC, Constantinou CL, Hartmann LC, Keeney GL, Suman VJ, Hillman DW, Podratz KC. Long-term follow-up of women with ovarian cancer after positive second-look laparotomy. Gynecol Oncol. 2003 Dec; 91(3):563-8.
    View PubMed
  74. Ingle JN, Suman VJ. Aromatase inhibitors versus tamoxifen for management of postmenopausal breast cancer in the advanced disease and neoadjuvant settings. J Steroid Biochem Mol Biol. 2003 Sep; 86(3-5):313-9.
    View PubMed
  75. Jatoi A, Suman VJ, Schaefer P, Block M, Loprinzi C, Roche P, Garneau S, Morton R, Stella PJ, Alberts SR, Pittelkow M, Sloan J, Pagano R. A phase II study of topical ceramides for cutaneous breast cancer. Breast Cancer Res Treat. 2003 Jul; 80(1):99-104.
    View PubMed
  76. Korndorfer SR, Lucas AR, Suman VJ, Crowson CS, Krahn LE, Melton LJ 3rd. Long-term survival of patients with anorexia nervosa: a population-based study in Rochester, Minn. Mayo Clin Proc. 2003 Mar; 78(3):278-84.
    View PubMed
  77. Markovic S, Suman V, Dalton R, Allred J, Wettstein P, Nevala W, Celis E, Alberts S, Fitch T, Egner J, Ebberts L, Tschetter L A Phase II Study of Aerosolized GM-CSF in the Treatm Cancer. 2003.
    View PubMed
  78. Long HJ 3rd, Rayson S, Podratz KC, Abu-Ghazaleh S, Suman V, Hartmann LC, Levitt R, Nair S, Hatfield AK, Knost JA. Long-term survival of patients with advanced/recurrent carcinoma of cervix and vagina after neoadjuvant treatment with methotrexate, vinblastine, doxorubicin, and cisplatin with or without the addition of molgramostim, and review of the literature. Am J Clin Oncol. 2002 Dec; 25(6):547-51.
    View PubMed
  79. Markovic S, Suman VJ, Dalton RJ, Woods JE, Fitzgibbons RJ Jr, Wold LE, Buckner JC, Kugler JW, Mailliard JA, Rowland KM, Krook JE, Brown DW, Tirona MT, Creagan ET. Randomized, placebo-controlled, phase III surgical adjuvant clinical trial of megestrol acetate (Megace) in selected patients with malignant melanoma. Am J Clin Oncol. 2002 Dec; 25(6):552-6.
    View PubMed
  80. Pisansky TM, Blute ML, Hillman DW, Davis BJ, Haddock MG, Suman VJ, Wilson TM, Zincke H. The relevance of prostatectomy findings for brachytherapy selection in patients with localized prostate carcinoma. Cancer. 2002 Aug 1; 95(3):513-9.
    View PubMed
  81. Perez EA, Geeraerts L, Suman VJ, Adjei AA, Baron AT, Hatfield AK, Maihle N, Michalak JC, Kuross SA, Kugler JW, Lafky JM, Ingle JN. A randomized phase II study of sequential docetaxel and doxorubicin/cyclophosphamide in patients with metastatic breast cancer. Ann Oncol. 2002 Aug; 13(8):1225-35.
    View PubMed
  82. Roche PC, Suman VJ, Jenkins RB, Davidson NE, Martino S, Kaufman PA, Addo FK, Murphy B, Ingle JN, Perez EA. Concordance between local and central laboratory HER2 testing in the breast intergroup trial N9831. J Natl Cancer Inst. 2002 Jun 5; 94(11):855-7.
    View PubMed
  83. Markovic SN, Suman VJ, Vukov AM, Fitch TR, Hillman DW, Adjei AA, Alberts SR, Kaur JS, Braich TA, Creagan ET. Phase II trial of KW2189 in patients with advanced malignant melanoma. Am J Clin Oncol. 2002 Jun; 25(3):308-12.
    View PubMed
  84. Witzig TE, Bossy B, Kimlinger T, Roche PC, Ingle JN, Grant C, Donohue J, Suman VJ, Harrington D, Torre-Bueno J, Bauer KD. Detection of circulating cytokeratin-positive cells in the blood of breast cancer patients using immunomagnetic enrichment and digital microscopy. Clin Cancer Res. 2002 May; 8(5):1085-91.
    View PubMed
  85. Okuno SH, Mailliard JA, Suman VJ, Edmonson JH, Creagan ET, Nair S, Levitt R, Kugler JW. Phase II study of methotrexate, vinblastine, doxorubicin, and cisplatin in patients with squamous cell carcinoma of the upper respiratory or alimentary passages of the head and neck. Cancer. 2002 Apr 15; 94(8):2224-31.
    View PubMed
  86. Maihle NJ, Lafky JM, Baron AT, Boardman CH, Greenwood TM, Christensen TA, Reiter JL, Cora EM, Lee H, Suman VJ, Fishman DA, Perez EA, Podratz KC. EGF receptor/ErbB isoforms as serum biomarkers in breast and ovarian cancer. Journal of Clinical Ligand Assay. 2002 Spr; 25(1):57-60.
    View PubMed
  87. Roche P, Suman V, Jenkins R, Davidson N, Martino S, Kaufman P, Addo F, Murphy B, Ingle J, Perez E Determination of HER-2 Status for the Breast Intergroup Trial N9831: Concordance Between Local and Central Laboratory Testing and the Correlation of Overexpression and Amplification Journal of the National Cancer Institute. 2002; 94:855-857.
    View PubMed
  88. Long HJ, Rayson S, Podratz KC, Abu-Ghazaleh S, Suman V, Buckner JC, Levitt R, Nair S, Hatfield AK, Kugler JW. Methotrexate, Vinblastine, Doxorubicin, and Cisplatin with or without the addition of molgramostim in women with advanced/recurrent cervix cancer. American Journal of Clinical Oncology. 2002; 25(6):547-551.
  89. Baron AT, Lafky JM, Suman VJ, Hillman DW, Buenafe MC, Boardman CH, Podratz KC, Perez EA, Maihle NJ. A preliminary study of serum concentrations of soluble epidermal growth factor receptor (sErbB1), gonadotropins, and steroid hormones in healthy men and women. Cancer Epidemiol Biomarkers Prev. 2001 Nov; 10(11):1175-85.
    View PubMed
  90. Gostout BS, Hartmann LC, Suman VJ, Fay NE, Jefferies JA, Morton RF, Gaffey TA, Farr GH, Tschetter LK, Abu-Ghazaleh S, Gallenberg MM, Hatfield AK. A randomized trial of interferon-alpha in cervical dysplasia. Int J Gynaecol Obstet. 2001 Aug; 74(2):207-10.
    View PubMed
  91. Schneekloth TD, Morse RM, Herrick LM, Suman VJ, Offord KP, Davis LJ Jr. Point prevalence of alcoholism in hospitalized patients: continuing challenges of detection, assessment, and diagnosis. Mayo Clin Proc. 2001 May; 76(5):460-6.
    View PubMed
  92. Edmonson JH, Suman VJ, Dalton RJ, Bro WC, Gallenberg MM, Long HJ, Levitt R, Hatfield AK, Krook JE, Mailliard JA, Gerstner JB, North Central Cancer Treatment Group. Comparison of conventional dose and double dose carboplatin in patients receiving cyclophosphamide plus carboplatin for advanced ovarian carcinoma: a North Central Cancer Treatment Group Study. Cancer Invest. 2001; 19(6):597-602.
    View PubMed
  93. Hanson Frost M, Suman VJ, Rummans TA, Dose AM, Taylor M, Novotny P, Johnson R, Evans RE. Physical, psychological and social well-being of women with breast cancer: the influence of disease phase. Psychooncology. 2000 May-Jun; 9(3):221-31.
    View PubMed
  94. Frost MH, Walsh Vockley C, Suman VJ, Greene MH, Zahasky K, Hartmann L. Perceived familial risk of cancer: health concerns and psychosocial adjustment. J Psychosoc Oncol. 2000; 18(1):63-82.
    View PubMed
  95. Madson TJ, Youdas JW, Suman VJ. Reproducibility of lumbar spine range of motion measurements using the back range of motion device. J Orthop Sports Phys Ther. 1999 Aug; 29(8):470-7.
    View PubMed
  96. Ingle JN, Suman VJ, Johnson PA, Krook JE, Mailliard JA, Wheeler RH, Loprinzi CL, Perez EA, Jordan VC, Dowsett M. Evaluation of tamoxifen plus letrozole with assessment of pharmacokinetic interaction in postmenopausal women with metastatic breast cancer. Clin Cancer Res. 1999 Jul; 5(7):1642-9.
    View PubMed
  97. Maguire-Boston EK, Suman V, Jacobsen SJ, Moore SB, Habermann TM, Cerhan JR, Folsom AR. Blood transfusion and risk of non-Hodgkin's lymphoma. Am J Epidemiol. 1999 Jun 15; 149(12):1113-8.
    View PubMed
  98. Creagan ET, Suman VJ, Dalton RJ, Pitot HC, Long HJ, Veeder MH, Vukov AM, Rowland KM, Krook JE, Michalak JC. Phase III clinical trial of the combination of cisplatin, dacarbazine, and carmustine with or without tamoxifen in patients with advanced malignant melanoma. J Clin Oncol. 1999 Jun; 17(6):1884-90.
    View PubMed
  99. Ingle JN, Suman VJ, Jordan VC, Dowsett M. Combination hormonal therapy involving aromatase inhibitors in the management of women with breast cancer. Endocr Relat Cancer. 1999 Jun; 6(2):265-9.
    View PubMed
  100. Rayson D, Adjei AA, Suman VJ, Wold LE, Ingle JN. Metaplastic breast cancer: prognosis and response to systemic therapy. Ann Oncol. 1999 Apr; 10(4):413-9.
    View PubMed
  101. Ingle JN, Suman VJ, Kardinal CG, Krook JE, Mailliard JA, Veeder MH, Loprinzi CL, Dalton RJ, Hartmann LC, Conover CA, Pollak MN. A randomized trial of tamoxifen alone or combined with octreotide in the treatment of women with metastatic breast carcinoma. Cancer. 1999 Mar 15; 85(6):1284-92.
    View PubMed
  102. Peethambaram PP, Ingle JN, Suman VJ, Hartmann LC, Loprinzi CL. Randomized trial of diethylstilbestrol vs. tamoxifen in postmenopausal women with metastatic breast cancer. An updated analysis. Breast Cancer Res Treat. 1999 Mar; 54(2):117-22.
    View PubMed
  103. Baron AT, Lafky JM, Boardman CH, Balasubramaniam S, Suman VJ, Podratz KC, Maihle NJ. Serum sErbB1 and epidermal growth factor levels as tumor biomarkers in women with stage III or IV epithelial ovarian cancer. Cancer Epidemiol Biomarkers Prev. 1999 Feb; 8(2):129-37.
    View PubMed
  104. Madison TJ, Youdas JW, Suman VJ, Hanson TJ. Reproducibility measurements of lumbar spine range of motion: A comparison of two methods. JOurnal of Orthopedic and Sports Physical Therapy. 1999; 29(8):470-477.
  105. Rayson D, Erlichman C, Suman VJ, Roche PC, Wold LE, Ingle JN, Donohue JH. Molecular markers in male breast carcinoma. Cancer. 1998 Nov 1; 83(9):1947-55.
    View PubMed
  106. Baron AT, Lafky JM, Connolly DC, Peoples J, O'Kane DJ, Suman VJ, Boardman CH, Podratz KC, Maihle NJ. A sandwich type acridinium-linked immunosorbent assay (ALISA) detects soluble ErbB1 (sErbB1) in normal human sera. J Immunol Methods. 1998 Oct 1; 219(1-2):23-43.
    View PubMed
  107. Creagan ET, Veeder MH, Suman VJ, Burch PA, Maples WJ, Schaefer PL, Pfeifle DM, Dalton RJ, Hatfield AK, Poon MA. A phase II study of high-dose cimetidine and the combination 5-fluorouracil, interferon alpha-2A, and leucovorin in advanced renal cell adenocarcinoma. Am J Clin Oncol. 1998 Oct; 21(5):475-8.
    View PubMed
  108. Stafford SL, Perry A, Suman VJ, Meyer FB, Scheithauer BW, Lohse CM, Shaw EG. Primarily resected meningiomas: outcome and prognostic factors in 581 Mayo Clinic patients, 1978 through 1988. Mayo Clin Proc. 1998 Oct; 73(10):936-42.
    View PubMed
  109. Rummans TA, Frost M, Suman VJ, Taylor M, Novotny P, Gendron T, Johnson R, Hartmann L, Dose AM, Evans RW. Quality of life and pain in patients with recurrent breast and gynecologic cancer. Psychosomatics. 1998 Sep-Oct; 39(5):437-45.
    View PubMed
  110. Stafford SL, Perry A, Leavitt JA, Garrity JA, Suman VJ, Scheithauer BW, Lohse CM, Meyer FB. Anterior visual pathway meningiomas primarily resected between 1978 and 1988: the Mayo Clinic Rochester experience. J Neuroophthalmol. 1998 Sep; 18(3):206-10.
    View PubMed
  111. Perry A, Stafford SL, Scheithauer BW, Suman VJ, Lohse CM. The prognostic significance of MIB-1, p53, and DNA flow cytometry in completely resected primary meningiomas. Cancer. 1998 Jun 1; 82(11):2262-9.
    View PubMed
  112. Yawn BP, Suman VJ, Jacobsen SJ. Maternal recall of distant pregnancy events. J Clin Epidemiol. 1998 May; 51(5):399-405.
    View PubMed
  113. Orvidas LJ, Olsen KD, Lewis JE, Suman VJ. Verrucous carcinoma of the larynx: a review of 53 patients. Head & Neck. 1998 May; 20(3):197-203.
    View PubMed
  114. Creagan ET, Hestorff RD, Suman VJ, Mailliard JA, Nair S, Krook JE, Kugler JW, Marschke RF Jr, Michalak JC, Tschetter LK. Combined levamisole with recombinant interleukin-2 (IL-2) in patients with advanced renal cell carcinoma: a phase II study. Am J Clin Oncol. 1998 Apr; 21(2):139-41.
    View PubMed
  115. Schiff D, Suman VJ, Yang P, Rocca WA, O'Neill BP. Risk factors for primary central nervous system lymphoma: a case-control study. Cancer. 1998 Mar 1; 82(5):975-82.
    View PubMed
  116. Moellentine C, Rummans T, Ahlskog JE, Harmsen WS, Suman VJ, O'Connor MK, Black JL, Pileggi T. Effectiveness of ECT in patients with parkinsonism. Journal of Neuropsychiatry & Clinical Neurosciences. 1998 Spring; 10(2):187-93.
    View PubMed
  117. Lundahl RE, Foote RL, Bonner JA, Suman VJ, Lewis JE, Kasperbauer JL, McCaffrey TV, Olsen KD. Combined neck dissection and postoperative radiation therapy in the management of the high-risk neck: a matched-pair analysis. Int J Radiat Oncol Biol Phys. 1998 Feb 1; 40(3):529-34.
    View PubMed
  118. Suman VJ, Van Winter JT, Evans MP, Simmons PS, Jacobsen SJ, Manolis AL. Levonorgestrel contraceptive implants in female patients 14 to 21 years old. Mayo Clin Proc. 1998 Jan; 73(1):10-6.
    View PubMed
  119. Creagan E, Hestorff R, Suman V, Mailliard J, Nair S, Krook J, Kugler J, Marschke R, Michalak J, Tschetter L A phase II study of combined Levamisole with recombinant Interleukin-2 (IL-2) in patients with advanced renal cell carcinoma Am J Clin Oncol. 1998; 21 (2):139-141.
    View PubMed
  120. Perry A, Stafford SL, Scheithauer BW, Suman VJ, Lohse CM. Meningioma grading: an analysis of histologic parameters. Am J Surg Pathol. 1997 Dec; 21(12):1455-65.
    View PubMed
  121. Aust MR, Olsen KD, Lewis JE, Nascimento AG, Meland NB, Foote RL, Suman VJ. Angiosarcomas of the head and neck: clinical and pathologic characteristics. Annals of Otology, Rhinology & Laryngology. 1997 Nov; 106(11):943-51.
    View PubMed
  122. Krahn LE, Reese MM, Rummans TA, Peterson GC, Suman VJ, Sharbrough FW, Cascino GD. Health care utilization of patients with psychogenic nonepileptic seizures. Psychosomatics. 1997 Nov-Dec; 38(6):535-42.
    View PubMed
  123. Houston MS, Silverstein MD, Suman VJ. Risk factors for 30-day mortality in elderly patients with lower respiratory tract infection. Community-based study. Arch Intern Med. 1997 Oct 27; 157(19):2190-5.
    View PubMed
  124. Lawrence JB, Conover CA, Haddad TC, Ingle JN, Reid JM, Ames MM, Suman VJ, Marks RS, Erlichman C, Hartmann LC. Evaluation of continuous infusion suramin in metastatic breast cancer: impact on plasma levels of insulin-like growth factors (IGFs) and IGF-binding proteins. Clin Cancer Res. 1997 Oct; 3(10):1713-20.
    View PubMed
  125. Creagan ET, Rowland KM Jr, Suman VJ, Kardinal CG, Marschke RF Jr, Marks RS, Maples WJ. Phase II study of combined levamisole with recombinant interleukin-2 in patients with advanced malignant melanoma. Am J Clin Oncol. 1997 Oct; 20(5):490-2.
    View PubMed
  126. Barrette BA, Srivatsa PJ, Cliby WA, Keeney GL, Suman VJ, Podratz KC, Roche PC. Overexpression of p34cdc2 protein kinase in epithelial ovarian carcinoma. Mayo Clin Proc. 1997 Oct; 72(10):925-9.
    View PubMed
  127. Srivatsa PJ, Cliby WA, Keeney GL, Suman VJ, Harmsen WS, Ziesmer SC, Roche PC, Podratz KC. Expression of nm23/nucleoside diphosphate kinase-A protein in endometrial carcinoma. Gynecol Oncol. 1997 Aug; 66(2):238-45.
    View PubMed
  128. Schiff D, O'Neill BP, Suman VJ. Spinal epidural metastasis as the initial manifestation of malignancy: clinical features and diagnostic approach. Neurology. 1997 Aug; 49(2):452-6.
    View PubMed
  129. Ingle JN, Johnson PA, Suman VJ, Gerstner JB, Mailliard JA, Camoriano JK, Gesme DH Jr, Loprinzi CL, Hatfield AK, Hartmann LC. A randomized phase II trial of two dosage levels of letrozole as third-line hormonal therapy for women with metastatic breast carcinoma. Cancer. 1997 Jul 15; 80(2):218-24.
    View PubMed
  130. Ania BJ, Suman VJ, Fairbanks VF, Rademacher DM, Melton LJ 3rd. Incidence of anemia in older people: an epidemiologic study in a well defined population. J Am Geriatr Soc. 1997 Jul; 45(7):825-31.
    View PubMed
  131. Dhodapkar M, Rubin J, Reid JM, Burch PA, Pitot HC, Buckner JC, Ames MM, Suman VJ. Phase I trial of temozolomide (NSC 362856) in patients with advanced cancer. Clin Cancer Res. 1997 Jul; 3(7):1093-100.
    View PubMed
  132. Hartmann LC, Tschetter LK, Habermann TM, Ebbert LP, Johnson PS, Mailliard JA, Levitt R, Suman VJ, Witzig TE, Wieand HS, Miller LL, Moertel CG. Granulocyte colony-stimulating factor in severe chemotherapy-induced afebrile neutropenia. N Engl J Med. 1997 Jun 19; 336(25):1776-80.
    View PubMed
  133. Gray DT, Suman VJ, Su WP, Clay RP, Harmsen WS, Roenigk RK. Trends in the population-based incidence of squamous cell carcinoma of the skin first diagnosed between 1984 and 1992. Arch Dermatol. 1997 Jun; 133(6):735-40.
    View PubMed
  134. Ingle JN, Kardinal CG, Suman VJ, Veeder MH, Schaefer PL, Kirschling RJ, Mailliard JA. Mitoxantrone dose augmentation utilizing filgrastim support in combination with fixed-dose 5-fluorouracil and leucovorin in women with metastatic breast cancer. Breast Cancer Res Treat. 1997 May; 43(3):193-200.
    View PubMed
  135. Ingle JN, Twito DI, Suman VJ, Krook JE, Maillard JA, Windschitl HE, Marschke RF Jr. Evaluation of intravenous 6-thioguanine as first-line chemotherapy in women with metastatic breast cancer. Am J Clin Oncol. 1997 Feb; 20(1):69-72.
    View PubMed
  136. Olsen KD, Lewis JE, Suman VJ. Spindle cell carcinoma of the larynx and hypopharynx. Otolaryngology - Head & Neck Surgery. 1997 Jan; 116(1):47-52.
    View PubMed
  137. Barrette B, Srivatsa P, Cliby W, Keeney G, Suman V, Podratz K, Roche P Over-expression of p34(cdc2) protein kinase in epithelial ovarian carcinoma. Mayo Clin Proc. 1997; 72(10):925-929.
    View PubMed
  138. Olsen KD, Meland NB, Aust MR, Lewis JE, Foote RL, Nascimento AG, Suman VJ. Angiosarcomas of the head and neck. Annals of Oncology Rhinology and Laryngology , 1997; 106(11):943-951.
  139. Pollak M, Ingle J, Suman VJ, Kugler J. Adjuvant therapy of cancer VIII In: SE Salmon (ed). Proceedings of the Eighth International Conference on the Adjuvant Therapy of Cancer JB Lippincott. 1997.
  140. Noyes WS, McCaffrey TV, Fabry DA, Robinette MS, Suman VJ. Effect of temperature elevation on rabbit cochlear function as measured by distortion-product otoacoustic emissions. Otolaryngol Head Neck Surg. 1996 Dec; 115(6):548-52.
    View PubMed
  141. Pisansky TM, Blute ML, Suman VJ, Bostwick DG, Earle JD, Zincke H. Correlation of pretherapy prostate cancer characteristics with seminal vesicle invasion in radical prostatectomy specimens. Int J Radiat Oncol Biol Phys. 1996 Oct 1; 36(3):585-91.
    View PubMed
  142. Glikson M, von Feldt LK, Suman VJ, Hayes DL. Short- and long-term results with an active-fixation, bipolar, polyurethane-insulated atrial pacing lead. Pacing Clin Electrophysiol. 1996 Oct; 19(10):1469-73.
    View PubMed
  143. Youdas JW, Garrett TR, Harmsen S, Suman VJ, Carey JR. Lumbar lordosis and pelvic inclination of asymptomatic adults. Phys Ther. 1996 Oct; 76(10):1066-81.
    View PubMed
  144. Youdas JW, Bogard CL, Suman JV. Level of intrateam agreement on candidate scores in a structured interview process. J Allied Health. 1996 Fall; 25(4):303-3.
    View PubMed
  145. Farnell GF, Buckner JC, Cascino TL, O'Connell MJ, Schomberg PJ, Suman V. Brain metastases from colorectal carcinoma. The long term survivors. Cancer. 1996 Aug 15; 78(4):711-6.
    View PubMed
  146. Hamel NW, Sebo TJ, Wilson TO, Keeney GL, Roche PC, Suman VJ, Hu TC, Podratz KC. Prognostic value of p53 and proliferating cell nuclear antigen expression in endometrial carcinoma. Gynecol Oncol. 1996 Aug; 62(2):192-8.
    View PubMed
  147. Miller CD, Laskowski ER, Suman VJ. Effect of corrective rearfoot orthotic devices on ground reaction forces during ambulation. Mayo Clin Proc. 1996 Aug; 71(8):757-62.
    View PubMed
  148. Srivatsa PJ, Cliby WA, Keeney GL, Dodson MK, Suman VJ, Roche PC, Podratz KC. Elevated nm23 protein expression is correlated with diminished progression-free survival in patients with epithelial ovarian carcinoma. Gynecol Oncol. 1996 Mar; 60(3):363-72.
    View PubMed
  149. Foote RL, Grado GL, Buskirk SJ, Olsen KD, Bonner JA, Earle JD, Kasperbauer JL, McCaffrey TV, Suman VJ. Radiation therapy for glottic cancer using 6-MV photons. Cancer. 1996 Jan 15; 77(2):381-6.
    View PubMed
  150. Pisansky TM, Zincke H, Suman VJ, Bostwick DG, Earle JD, Oesterling JE. Correlation of pre-therapy prostate cancer characteristics with histologic findings from pelvic lymphadenectomy specimens. Int J Radiat Oncol Biol Phys. 1996 Jan 1; 34(1):33-39.
    View PubMed
  151. Ingle JN, Kardinal CG, Suman VJ, Krook JE, Hatfield AK. Octreotide as first-line treatment for women with metastatic breast cancer. Invest New Drugs. 1996; 14(2):235-7.
    View PubMed
  152. Rasmussen NH, Colligan RC, Suman VJ. An investigation of clinic-based laboratory measures in the differential diagnosis of attention-deficit hyperactivity disorder (ADHD) versus externalizing disruptive behavior disorder. Archives of clinical Neuropsychology. 1996; 11(5):439-440.
  153. Lynn S, Pool A, Rose D, Brey R, Suman V. Randomized trial of the canalith repositioning procedure. Otolaryngology - Head & Neck Surgery. 1995 Dec; 113(6):712-20.
    View PubMed
  154. Carey JR, Bogard CL, Youdas JW, Suman VJ. Stimulus-response compatibility effects in a manual tracking task. Percept Mot Skills. 1995 Dec; 81(3 Pt 2):1155-70.
    View PubMed
  155. Soundy TJ, Lucas AR, Suman VJ, Melton LJ. Bulimia nervosa in Rochester, Minnesota from 1980 to 1990. Psychol Med. 1995 Sep; 25(5):1065-71.
    View PubMed
  156. Houston MS, Silverstein MD, Suman VJ. Community-acquired lower respiratory tract infection in the elderly: a community-based study of incidence and outcome. J Am Board Fam Pract. 1995 Sep-Oct; 8(5):347-56.
    View PubMed
  157. Brey RH, Facer GW, Trine MB, Lynn SG, Peterson AM, Suman VJ. Vestibular effects associated with implantation of a multiple channel cochlear prosthesis. Am J Otol. 1995 Jul; 16(4):424-30.
    View PubMed
  158. Safavi KH, Muller SA, Suman VJ, Moshell AN, Melton LJ 3rd. Incidence of alopecia areata in Olmsted County, Minnesota, 1975 through 1989. Mayo Clin Proc. 1995 Jul; 70(7):628-33.
    View PubMed
  159. Evans MP, Webb MJ, Gaffey TA, Katzmann JA, Suman VJ, Hu TC. DNA ploidy of ovarian granulosa cell tumors. Lack of correlation between DNA index or proliferative index and outcome in 40 patients. Cancer. 1995 May 1; 75(9):2295-8.
    View PubMed
  160. Hayes DL, Graham KJ, Irwin M, Vidaillet H, Disler G, Sweesy M, Kincaid D, Osborn MJ, Suman VJ, Neubauer SA. Multicenter experience with a bipolar tined polyurethane ventricular lead. Pacing & Clinical Electrophysiology. 1995 May; 18(5 Pt 1):999-1004.
    View PubMed
  161. Tomlinson FH, Kurtin PJ, Suman VJ, Scheithauer BW, O'Fallon JR, Kelly PJ, Jack CR Jr, O'Neill BP. Primary intracerebral malignant lymphoma: a clinicopathological study of 89 patients. J Neurosurg. 1995 Apr; 82(4):558-66.
    View PubMed
  162. Thomson SP, Gibbons RJ, Smars PA, Suman VJ, Pierre RV, Santrach PJ, Jiang NS. Incremental value of the leukocyte differential and the rapid creatine kinase-MB isoenzyme for the early diagnosis of myocardial infarction. Ann Intern Med. 1995 Mar 1; 122(5):335-41.
    View PubMed
  163. Reeder GS, Bryant SC, Suman VJ, Holmes DR Jr. Intracoronary thrombus: still a risk factor for PTCA failure? Cathet Cardiovasc Diagn. 1995 Mar; 34(3):191-5.
    View PubMed
  164. Crotty TB, Li CY, Edwards WD, Suman VJ. Amyloidosis and endomyocardial biopsy: correlation of extent and pattern of deposition with amyloid immunophenotype in 100 cases. Cardiovasc Pathol. 1995 Jan-Mar; 4:39-42.
  165. Youdas JW, Suman VJ, Garrett TR. Reliability of measurements of lumbar spine sagittal mobility obtained with the flexible curve. J Orthop Sports Phys Ther. 1995 Jan; 21(1):13-20.
    View PubMed
  166. Baron AT, Suman VJ, Nemeth E, Salisbury JL. The pericentriolar lattice of PtK2 cells exhibits temperature and calcium-modulated behavior. J Cell Sci. 1994 Nov; 107 ( Pt 11):2993-3003.
    View PubMed
  167. Ania BJ, Suman VJ, Sobell JL, Codd MB, Silverstein MN, Melton LJ. Trends in the incidence of polycythemia vera among Olmsted County, Minnesota residents, 1935-1989. Am J Hematol. 1994 Oct; 47(2):89-93.
    View PubMed
  168. Youdas JW, Carey JR, Garrett TR, Suman VJ. Reliability of goniometric measurements of active arm elevation in the scapular plane obtained in a clinical setting. Arch Phys Med Rehabil. 1994 Oct; 75(10):1137-44.
    View PubMed
  169. Foote RL, Olsen KD, Buskirk SJ, Stanley RJ, Suman VJ. Laryngectomy alone for T3 glottic cancer. Head Neck. 1994 Sep-Oct; 16(5):406-12.
    View PubMed
  170. Thomas JV, Olsen KD, Neel HB 3rd, DeSanto LW, Suman VJ. Recurrences after endoscopic management of early (T1) glottic carcinoma. Laryngoscope. 1994 Sep; 104(9):1099-104.
    View PubMed
  171. Glikson M, Vonfeldt LK, Suman VJ, Hayes DL. Clinical surveillance of an active fixation, bipolar, polyurethane insulated pacing lead. 2. The ventricular lead. Pacing Clin Electrophysiol. 1994 Sep; 17:1499-1502.
    View PubMed
  172. Ania BJ, Suman VJ, Fairbanks VF, Melton LJ 3rd. Prevalence of anemia in medical practice: community versus referral patients. Mayo Clin Proc. 1994 Aug; 69(8):730-5.
    View PubMed
  173. Glikson M, Vonfeldt LK, Suman VJ, Hayes DL. Clinical surveillance of an active fixation, bipolar, polyurethane insulated pacing lead. 1. The atrial lead. Pacing Clin Electrophysiol. 1994 Aug; 17:1399-1404.
    View PubMed
  174. Carey JR, Bogard CL, King BA, Suman VJ. Finger-movement tracking scores in healthy subjects. Perceptual & Motor Skills. 1994 Aug; 79(1 Pt 2):563-76.
    View PubMed
  175. Thomas JV, Olsen KD, Neel HB 3rd, DeSanto LW, Suman VJ. Early glottic carcinoma treated with open laryngeal procedures. Archives of Otolaryngology -- Head & Neck Surgery. 1994 Mar; 120(3):264-8.
    View PubMed
  176. Stormont TJ, Suman VJ, Oesterling JE. Newly diagnosed bulbar urethral strictures: etiology and outcome of various treatments. J Urol. 1993 Nov; 150(5 Pt 2):1725-8.
    View PubMed
  177. Oesterling JE, Suman VJ, Zincke H, Bostwick DG. PSA-detected (clinical stage T1c or B0) prostate cancer. Pathologically significant tumors. Urol Clin North Am. 1993 Nov; 20(4):687-93.
    View PubMed
  178. Suman VJ, Atkinson EJ, O'Fallon WM, Black DM, Melton LJ 3rd. A nomogram for predicting lifetime hip fracture risk from radius bone mineral density and age. Bone. 1993 Nov-Dec; 14(6):843-6.
    View PubMed
  179. Youdas JW, Bogard CL, Suman VJ. Reliability of goniometric measurements and visual estimates of ankle joint active range of motion obtained in a clinical setting. Arch Phys Med Rehabil. 1993 Oct; 74(10):1113-8.
    View PubMed
  180. Suman VJ, Tazelaar HD, Bailey K, Melton J, Longaker MT, Stern R, Finkbeiner WE. Are patients with neoplasia at an increased risk for cardiac myxomas? Hum Pathol. 1993 Sep; 24(9):1008-11.
    View PubMed
  181. Foote RL, Robinow JS, Shaw EG, Kline RW, Suman VJ, Ilstrup DM, Lee RE. Low-versus high-energy photon beams in radiotherapy for lung cancer. Med Dosim. 1993 Summer; 18(2):65-72.
  182. Cersosimo E, Gharib H, Suman VJ, Goellner JR. "Suspicious" thyroid cytologic findings: outcome in patients without immediate surgical treatment. Mayo Clin Proc. 1993 Apr; 68(4):343-8.
    View PubMed
  183. Oesterling JE, Andrews PE, Suman VJ, Zincke H, Myers RP. Preoperative androgen deprivation therapy: artificial lowering of serum prostate specific antigen without downstaging the tumor. J Urol. 1993 Apr; 149(4):779-82.
    View PubMed
  184. Olsen KD, Thomas JV, DeSanto LW, Suman VJ. Indications and results of cordectomy for early glottic carcinoma. Otolaryngology - Head & Neck Surgery. 1993 Mar; 108(3):277-82.
    View PubMed
  185. O'Brien T, Gharib H, Suman VJ, van Heerden JA. Treatment of toxic solitary thyroid nodules: surgery versus radioactive iodine. Surgery. 1992 Dec; 112(6):1166-70.
    View PubMed
  186. Youdas JW, Garrett TR, Suman VJ, Bogard CL, Hallman HO, Carey JR. Normal range of motion of the cervical spine: an initial goniometric study. Phys Ther. 1992 Nov; 72(11):770-80.
    View PubMed